Treatment of inflammation, demyelination and neuronal/axonal loss

Details for Australian Patent Application No. 2007308158 (hide)

Owner GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH

Inventors Hallenbeck, John M.; Wakita, Hideaki; Shukaliak-Quandt, Jacqueline A.

Agent Griffith Hack

Pub. Number AU-A-2007308158

PCT Pub. Number WO2008/045488

Priority 60/828,732 09.10.06 US; 60/905,741 08.03.07 US

Filing date 9 October 2007

Wipo publication date 17 April 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/045488 Priority application(s): WO2008/045488

18 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 May 2009

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the applicant name from GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH to Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007308168-Kidney-derived cells and methods of use in tissue repair and regeneration

2007308154-N-aryl pyrazole compounds for use against diabetes